Article Details
Retrieved on: 2022-01-03 15:46:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration.
Article found on: investorplace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here